MONTREAL — A combination of intravenous immunoglobulin (IVIg) and methylprednisolone (MP) was associated with greater improvement in disability in patients with chronic inflammatory demyelinating ...
Treatment with intravenous immunoglobulins (IVIG) for dermatomyositis was effective in a pivotal phase III randomized trial, a researcher reported. At week 16, 78.72% of patients receiving IVIG were ...
The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of ...
March 26, 2012 — The American Academy of Neurology (AAN) has published an evidence-based guideline on the use of intravenous immunoglobulin (IVIg) in the treatment of neuromuscular disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results